title: Stem cell patents after the america invents act.
abstract: Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
authors.affiliation: Innovation Center for Law and Technology, New York Law School, New York, NY 10013, USA. Electronic address: jacob.sherkow@nyls.edu.
authors.forename: Jacob S
authors.initials: JS
authors.lastname: Sherkow
authors.affiliation: Program on Stem Cells in Society, Center for Biomedical Ethics, Stanford School of Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: cscott@stanford.edu.
authors.forename: Christopher Thomas
authors.initials: CT
authors.lastname: Scott
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000331:legislation & jurisprudence*; D034462:Dissent and Disputes / Q000331:legislation & jurisprudence; D006801:Humans; D062069:Inventions / Q000331:legislation & jurisprudence* / Q000706:statistics & numerical data; D007603:Jurisprudence; D010330:Patents as Topic; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence*; D013234:Stem Cells / Q000502:physiology*; D014481:United States